The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real world incidence, prevention, and management of tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with venetoclax in the inpatient and outpatient settings.
 
Yannis Valtis
Consulting or Advisory Role - EasyRx
 
David Nemirovsky
No Relationships to Disclose
 
Andriy Derkach
No Relationships to Disclose
 
Lindsey Elizabeth Roeker
Stock and Other Ownership Interests - Abbott Laboratories (I); Abbvie (I)
Honoraria - Aptitude Health; DAVA Oncology; Medscape; OncLive/MJH Life Sciences; Peerview; Pfizer; Prova Education; Vaniam Group
Consulting or Advisory Role - Abbvie; Ascentage Pharma; AstraZeneca; BeiGene; Janssen; Loxo/Lilly; Nurix; Pharmacyclics; Pharmacyclics; TG Therapeutics
Research Funding - Adaptive Biotechnologies (Inst); Aptose Biosciences (Inst); AstraZeneca (Inst); DAAN Biotherapeutics (Inst); Genentech (Inst); Loxo/Lilly (Inst); Pfizer (Inst); Qilu Puget Sound Biotherapeutics (Inst)
Travel, Accommodations, Expenses - Loxo/Lilly; Vaniam Group
 
Saumya Sharan
No Relationships to Disclose
 
Charlene Kabel
No Relationships to Disclose
 
Ricardo Ortiz
No Relationships to Disclose
 
Mark Blaine Geyer
Consulting or Advisory Role - Bioheng; Jazz Pharmaceuticals; Sanofi; Takeda
Research Funding - Actinium Pharmaceuticals (Inst); Amgen (Inst); Sanofi
Travel, Accommodations, Expenses - Takeda